A phase II randomised control trial of high dose vitamin D in localised prostate cancer patients with intermediate risk of disease progression - ProsD Principal Investigator: Professor Howard Gurney

Visalini Nair-Shalliker; Albert Bang; Sam Egger; Jennifer Rodger; Mark Clements; Robert A. Gardiner; Anne Kricker; Markus Seibel; Suzanne K. Chambers; Michael G. Kimlin; Bruce K. Armstrong; David P. Smith

A phase II randomised control trial of high dose vitamin D in localised prostate cancer patients with intermediate risk of disease progression - ProsD Principal Investigator: Professor Howard Gurney

Visalini Nair-Shalliker, Albert Bang, Sam Egger, Jennifer Rodger, Mark Clements, Robert A. Gardiner, Anne Kricker, Markus Seibel, Suzanne K. Chambers, Michael G. Kimlin, Bruce K. Armstrong, David P. Smith

Population and Public Health

Research output: Contribution to journal › Abstract/Meeting Abstract › peer-review

Original language	English
Pages (from-to)	30-31
Number of pages	2
Journal	BJU International
Volume	122
Publication status	Published - Aug 2018
Event	19th Asia Pacific Prostate Cancer Conference - Brisbane Convention & Exhibition Centre, Brisbane, Australia Duration: 22 Aug 2018 → 25 Aug 2018 https://www.continence.org.au/events_calendar.php/436/19th-asia-pacific-prostate-cancer-conference (Conference website)

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

Nair-Shalliker, V., Bang, A., Egger, S., Rodger, J., Clements, M., Gardiner, R. A., Kricker, A., Seibel, M., Chambers, S. K., Kimlin, M. G., Armstrong, B. K., & Smith, D. P. (2018). A phase II randomised control trial of high dose vitamin D in localised prostate cancer patients with intermediate risk of disease progression - ProsD Principal Investigator: Professor Howard Gurney. BJU International, 122, 30-31.

@article{3ef66a79815342f58b4803aed26118ff,

title = "A phase II randomised control trial of high dose vitamin D in localised prostate cancer patients with intermediate risk of disease progression - ProsD Principal Investigator: Professor Howard Gurney",

author = "Visalini Nair-Shalliker and Albert Bang and Sam Egger and Jennifer Rodger and Mark Clements and Gardiner, {Robert A.} and Anne Kricker and Markus Seibel and Chambers, {Suzanne K.} and Kimlin, {Michael G.} and Armstrong, {Bruce K.} and Smith, {David P.}",

year = "2018",

month = aug,

language = "English",

volume = "122",

pages = "30--31",

journal = "British Journal of Urology International",

issn = "1464-410X",

publisher = "John Wiley & Sons",

note = "19th Asia Pacific Prostate Cancer Conference ; Conference date: 22-08-2018 Through 25-08-2018",

url = "https://www.continence.org.au/events_calendar.php/436/19th-asia-pacific-prostate-cancer-conference",

}

Nair-Shalliker, V, Bang, A, Egger, S, Rodger, J, Clements, M, Gardiner, RA, Kricker, A, Seibel, M, Chambers, SK, Kimlin, MG, Armstrong, BK & Smith, DP 2018, 'A phase II randomised control trial of high dose vitamin D in localised prostate cancer patients with intermediate risk of disease progression - ProsD Principal Investigator: Professor Howard Gurney', BJU International, vol. 122, pp. 30-31.

A phase II randomised control trial of high dose vitamin D in localised prostate cancer patients with intermediate risk of disease progression - ProsD Principal Investigator: Professor Howard Gurney. / Nair-Shalliker, Visalini; Bang, Albert; Egger, Sam et al.
In: BJU International, Vol. 122, 08.2018, p. 30-31.

Research output: Contribution to journal › Abstract/Meeting Abstract › peer-review

TY - JOUR

T1 - A phase II randomised control trial of high dose vitamin D in localised prostate cancer patients with intermediate risk of disease progression - ProsD Principal Investigator

T2 - 19th Asia Pacific Prostate Cancer Conference

AU - Nair-Shalliker, Visalini

AU - Bang, Albert

AU - Egger, Sam

AU - Rodger, Jennifer

AU - Clements, Mark

AU - Gardiner, Robert A.

AU - Kricker, Anne

AU - Seibel, Markus

AU - Chambers, Suzanne K.

AU - Kimlin, Michael G.

AU - Armstrong, Bruce K.

AU - Smith, David P.

PY - 2018/8

Y1 - 2018/8

M3 - Abstract/Meeting Abstract

SN - 1464-410X

VL - 122

SP - 30

EP - 31

JO - British Journal of Urology International

JF - British Journal of Urology International

Y2 - 22 August 2018 through 25 August 2018

ER -